Clinical Trial Update: Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin for enhanced analgesia in chronic neuropathic pain is currently recruiting, sponsored by Unity Health Toronto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Chronic Neuropathic Pain, Pain Management | Phase 2 | Status: RECRUITING